Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

Inclusion Criteria: * Are at least 18 years of age at Visit 1 (Day 1, Baseline) of either sex and any race. * Signature of the subject or legally authorized representative on the Informed Consent Form. * Are willing and able to follow all instructions and attend all study visits. * Are willing to avoid disallowed medication for the duration of the study. * If female is of childbearing potential, agree to and submit a urine sample for pregnancy testing. Post menopausal is defined as having no menses for at least 12 consecutive months. * Additional inclusion criteria also apply. Exclusion Criteria: * Have known sensitivity or poor tolerance to any component of the Investigational Drug. * Have an acute ocular infection (bacterial, viral or fungal) or active ocular inflammation other than Blepharitis in the study eye. * Have used topical corticosteroid medications or topical ophthalmic solutions that the investigator feels may interfere with the study parameters. * Have used any non-diagnostic topical ophthalmic solutions in the study eye. * Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a positive urine pregnancy test. * Currently suffer from alcohol and/or drug abuse. * Have prior (within 30 days of beginning dosing) or anticipated concurrent use of an investigational drug or device. * Have a condition or a situation which, in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation. * Additional exclusion criteria also apply.